James serves as the UK/EU bureau chief for Fierce Biotech, a role he assumed in April 2022. Previously, he led S&P Global Market Intelligence’s healthcare industry coverage, focusing on the pharma, biotech, and hospital sectors. Before that, James spent eight years at Chemist and Druggist magazine, including four years as its editor, covering the U.K. community pharmacy sector. In his free time, he enjoys collecting records and running through London’s suburbs.